3-methylcholanthrene has been researched along with Paraneoplastic Syndromes in 3 studies
Methylcholanthrene: A carcinogen that is often used in experimental cancer studies.
3-methylcholanthrene : A pentacyclic ortho- and peri-fused polycyclic arene consisting of a dihydrocyclopenta[ij]tetraphene ring system with a methyl substituent at the 3-position.
Paraneoplastic Syndromes: In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tereshchenko, IP | 1 |
Kashulina, AP | 1 |
Aleksandrova, LM | 1 |
Makino, T | 1 |
Noguchi, Y | 1 |
Ito, T | 1 |
Matsumoto, A | 1 |
von Metzler, A | 1 |
Nitsch, C | 1 |
3 other studies available for 3-methylcholanthrene and Paraneoplastic Syndromes
Article | Year |
---|---|
[Hemocytes and the pathogenesis of malignant growth].
Topics: Adrenocortical Hyperfunction; Animals; Erythrocyte Count; Erythrocyte Membrane; Erythrocytes, Abnorm | 1983 |
Ultrastructural alterations of hepatocytes in the tumour-bearing, cachectic rat.
Topics: Animals; Body Weight; Cachexia; Endoplasmic Reticulum; Liver; Male; Methylcholanthrene; Microscopy, | 1994 |
Carcinogenesis and the central nervous system.
Topics: Animals; Antineoplastic Agents; Brain; Brain Diseases; Central Nervous System Agents; Electroencepha | 1986 |